Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure

Jonas Willmann, Joost J.C. Verhoeff, Orit Kaidar-Person, André Abrunhosa-Branquinho, Enrico Clementel, Coreen Corning, Daniel Portik, Luiza Souza, Jaap C. Reijneveld, Frederic Dhermain, Coen Hurkmans, Angelo Filippo Monti, Jordi Saez, Warren P. Mason, Michael Weller, Patrick Roth, Nicolaus Andratschke

Open source

DOI: 10.1016/j.radonc.2025.111088
Published: 2025-10
Container: Radiotherapy and Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.radonc.2025.111088,
  title = {Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure},
  author = {Jonas Willmann and Joost J.C. Verhoeff and Orit Kaidar-Person and André Abrunhosa-Branquinho and Enrico Clementel and Coreen Corning and Daniel Portik and Luiza Souza and Jaap C. Reijneveld and Frederic Dhermain and Coen Hurkmans and Angelo Filippo Monti and Jordi Saez and Warren P. Mason and Michael Weller and Patrick Roth and Nicolaus Andratschke},
  year = {2025},
  journal = {Radiotherapy and Oncology},
  doi = {10.1016/j.radonc.2025.111088},
  url = {https://doi.org/10.1016/j.radonc.2025.111088}
}

RIS

TY  - JOUR
TI  - Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure
AU  - Jonas Willmann
AU  - Joost J.C. Verhoeff
AU  - Orit Kaidar-Person
AU  - André Abrunhosa-Branquinho
AU  - Enrico Clementel
AU  - Coreen Corning
AU  - Daniel Portik
AU  - Luiza Souza
AU  - Jaap C. Reijneveld
AU  - Frederic Dhermain
AU  - Coen Hurkmans
AU  - Angelo Filippo Monti
AU  - Jordi Saez
AU  - Warren P. Mason
AU  - Michael Weller
AU  - Patrick Roth
AU  - Nicolaus Andratschke
PY  - 2025
JO  - Radiotherapy and Oncology
DO  - 10.1016/j.radonc.2025.111088
UR  - https://doi.org/10.1016/j.radonc.2025.111088
ER  -

APA

Willmann, J., Verhoeff, J. J., Kaidar-Person, O., Abrunhosa-Branquinho, A., Clementel, E., Corning, C., Portik, D., Souza, L., Reijneveld, J. C., Dhermain, F., Hurkmans, C., Monti, A. F., Saez, J., Mason, W. P., Weller, M., Roth, P., & Andratschke, N. (2025). Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedure. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2025.111088

Source records

crossref · retrieved 2026-09-26T04:26:50.370Z